{"id":121747,"title":"Saccade: World's Earliest Test for Alzheimer's Biomarkers","tagline":"World's Earliest Test for Alzheimer's Biomarkers","body":"**TL;DR:** Saccade is a 15-minute VR test that catches Alzheimer’s biomarkers earlier than ever before. That lets people start lifestyle changes and new FDA-approved drugs years sooner, when they work best. Sometimes that pushes symptoms past life expectancy, so they never show up. \\\nWe’re live in San Francisco clinics, testing people in their 30s and older for early risk indicators. \\\nYou can book a test at [saccade.health](http://saccade.health) today.\\\n\\\n<https://youtu.be/2H0dh5Hnd_Q>\n\n**Problem**\\\nCurrent Alzheimer's testing only screens patients after clear symptoms appear, at which point an individual has already suffered significant cognitive decline. New FDA-approved drugs have been proven to slow this decline, but not reverse it. By the time most people get their diagnosis, they've missed their best window to act.\n\n**Insight**\\\nEye movement changes linked to Alzheimer's can be detected up to 15 years before symptoms appear - earlier than any other markers we can screen for. Our product is designed to service those exact changes, giving patients the insight they need to act now.\n\n![uploaded image](/media/?type=post&id=121747&key=user_uploads/2316918/a60db064-10c6-4ca0-bd9c-29389ea2ef4f)\n\n**Product**\n\n* **Tasks:** users complete visual tasks designed by neurologists that trigger distinct oculomotor responses in people with early-stage, pre-symptomatic Alzheimer's\n* **Hardware:** our patent-pending attachment connects to any VR headset on the market and captures high-precision recordings of eye movement patterns.\n* **Analysis:** the patterns are analyzed by our proprietary ML model to produce a risk score.\n\n**Next Steps for Patients**\\\nOnce classified into one of three risk categories, patients can start interventions ranging from preventative longevity practices, further neurological evaluations, and new FDA-approved drugs. Starting treatment early can significantly slow the progression of the disease, allowing some patients to outlive the onset of symptoms and never suffer from memory loss in their lifetime.\n\n**Get tested today: Sign up at [saccade.health](http://saccade.health) and schedule a screening today.**\n\n**Asks**\\\nIntros to US longevity practices and clinics that want to offer early Alzheimer’s testing to their patients. The test takes 10 minutes. I’m happy to meet in person: [shreyas@saccade.health](mailto:shreyas@saccade.health)\n\n![uploaded image](/media/?type=post&id=121747&key=user_uploads/2316918/51c6bcc9-d56f-4332-be61-510f5525d259)\n\n","slug":"Vff-saccade-world-s-earliest-test-for-alzheimer-s-biomarkers","created_at":"2026-10-13T18:00:00.187Z","updated_at":"2026-11-18T08:35:20.313Z","total_vote_count":8,"url":"https://www.ycombinator.com/launches/Vff-saccade-world-s-earliest-test-for-alzheimer-s-biomarkers","share_image_url":"//bookface-static.ycombinator.com/assets/ycdc/yc-og-image-c440a0ad1dacfb86eeeb343717479cc54d256614449b4ef719977a0a451f8bc8.png","company":{"id":34862,"name":"Saccade","slug":"saccade","url":"https://saccade.health","logo":"https://bookface-images.s3.amazonaws.com/small_logos/e30db37d0cbb762632d614afb3918a8e0b4131cb.png","batch":"Fall 2026","industry":"Healthcare","tags":["Hard Tech","Hardware","Machine Learning","B2B","Healthcare"],"search_path":"https://bookface.ycombinator.com/company/34862"}}